Search Browse Earnings

enVVeno Medical Corp

Nasdaq:NVNO

Surgical & Medical Instruments & Apparatus·IRVINE, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Berman Robert Andrew

Revenue

$31,243

-83.3% YoY

FY 2020

Adj. EBITDA

-$25.0M

-80075.5% margin

FY 2024

Net Income

-$23.5M

-75268.1% margin

FY 2024

EPS (Diluted)

-$1.91

FY 2024

Stock Price

$10.87

-9.4%

2026-03-12

52W Range

$8.67 – $196.70

P/E Ratio

-5.7x

Market Cap

$219.8M

Cash

$3.6M

FY 2024

Total Debt

$312,700

FY 2021

Net Cash

$3.3M

FY 2021

Enterprise Value

$216.5M

Debt / EBITDA

0.1x

FY 2020

EV / EBITDA

-8.7x

Employees

—